Simplex Trading’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$60.5K Sell
900
-2,500
-74% -$185K ﹤0.01% 5659
2025
Q4
$269K Buy
3,400
+3,200
+1,600% +$218K ﹤0.01% 3929
2025
Q3
$6K Buy
+200
New +$4.92K ﹤0.01% 8195
2024
Q4
Sell
-28,500
Closed -$446K 9028
2024
Q3
$446K Buy
+28,500
New +$400K ﹤0.01% 3716

Other funds holding INBX

Simplex Trading's INBX Position: Q1 2026 in Review

Simplex Trading sold out of Inhibrx (INBX) in Q1 2026, closing a stake of 1,145 shares — an estimated $84.9K sold.

Simplex Trading first reported a position in INBX in Q3 2024 and held it in 3 quarters. The position peaked at $90.5K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Simplex Trading reported no remaining Inhibrx position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,145 Inhibrx shares in Q1 2026, an estimated $84.9K.
  • Simplex Trading first reported a position in Inhibrx in Q3 2024 and held it in 3 quarters.
  • Simplex Trading's Inhibrx position peaked at $90.5K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.